BioRestorative Therapies, Inc. - BRTX

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$282K
QoQ value delta ($000)
-$96K (-25.4%)
Implied price effect (QoQ)
-68.13%
Shares
Total shares
765,898
QoQ shares delta
+438,724 (+134.1%)
Total shares held by funds (by quarter)

Market chart (BRTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 14 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 103 88,778 0.0%
CITADEL ADVISORS LLC 64 238,606 0.0%
GEODE CAPITAL MANAGEMENT, LLC 60 223,083 0.0%
UBS Group AG 27 99,832 0.0%
WEALTH ALLIANCE, LLC 10 40,000 0.0%
VANGUARD FIDUCIARY TRUST CO 10 39,452 0.0%
STATE STREET CORP 8 32,459 0.0%
Tower Research Capital LLC (TRC) 0 1,462 0.0%
OSAIC HOLDINGS, INC. 0 2,000 0.0%
Parallel Advisors, LLC 0 1 0.0%
Cornerstone Planning Group LLC 0 11 0.0%
SBI Securities Co., Ltd. 0 199 0.0%
TD Waterhouse Canada Inc. 0 3 0.0%
Rossby Financial, LCC 0 11 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%